193
Participants
Start Date
September 7, 2021
Primary Completion Date
October 2, 2024
Study Completion Date
October 2, 2024
Magrolimab
Administered intravenously
Pembrolizumab
Administered intravenously
Docetaxel
Administered intravenously
5-FU
Administered intravenously
Cisplatin
Administered intravenously
Carboplatin
Administered intravenously
Zimberelimab
Administered intravenously
St. Vincent's Hospital Sydney, Darlinghurst
ZiekenhuisNetwerk Antwerpen (ZNA) - Stuivenberg, Antwerp
Macquarie University, Macquarie Park
Blacktown Hospital, Westmead
UZ Antwerpen, Edegem
Narodowy Instytut Onkologii im. M. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Klinika Nowotworow Glowy i Szyi, Warsaw
AZ Sint-Maarten, Mechelen
Algemeen Ziekenhuis Klina, Brasschaat
Universitaire Ziekenhuis Leuven, Leuven
Alfred Health, Melbourne
Austin Health, Heidelberg
Princess Alexandra Hospital, Woolloongabba
Universitäres Krebszentrum Leipzig, Leipzig
University of the Sunshine Coast, Sippy Downs
Cairns Hospital, Cairns
CHU UCL Namur - Sainte-Elisabeth, Namur
Centre de Lutte Contre le Cancer (CLCC) - Centre Antoine Lacassagne (CAL) - Site Est, Nice
Centre Hospitalizer De L'Ardenne, Libramont-Chevigny
Hospital del Mar, Barcelona
Hospital De La Santa Creu I Sant Pau, Barcelona
Icahn School of Medicine at Mount Sinai and the Mount Sinai Hospital, New York
Charite University Medicine, Berlin
New York Cancer and Blood Specialists, Port Jefferson Station
Hopital de la Timone, Marseille
Lancaster General Hospital, Lancaster
Fondazione IRCCS Istituto Nazionale Tumori Milano, Milan
Centre Georges François Leclerc, Dijon
Kath. Marienkrankenhaus gGmbH, Hamburg
Hospital Universitario de Jaen, Jaén
ASST degli Spedali Civili di Brescia, Brescia
Hospital General Universitario Gregorio Maranon, Madrid
MD Anderson Cancer Center, Madrid
Hospital Universitario La Paz, Madrid
Hospital Regional Universitario de Malaga, Málaga
Medical University of South Carolina, Charleston
University Center and Blood Center,LLC., Athens
Clinica Universidad de Navarra, Pamplona
Institut Bergonie, Bordeaux
Memorial Healthcare System, Hollywood
Ocala Oncology Center, Ocala
Universitatsmedizin Gottingen, GÃttingen
Azienda Ospedaliero - Universitaria di Bologna - IRCCS, Bologna
Hospital Universitario Virgen Macarena, Seville
Hospital Universitario Virgen del Rocio, Seville
Azienda Ospedaliero-Universitaria di Modena - Policlinico, Modena
Arcispedale Santa Maria Nuova, Reggio Emilia
Hospital Universitari i Politecnic La Fe, Valencia
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
Azienda Ospedaliero - Universitaria Senese, Siena
Universitätsklinikum Bonn, Medizinische Klinik und Poliklinik III, Bonn
Ospedale San Luca Luca, Lucca
Virginia Piper Cancer Center (Alliant Health, Minneapolis
Avera Cancer Institute, Sioux Falls
Sanford Roger Maris Cancer Center, Fargo
Washington University of Medicine- Siteman Cancer Center, St Louis
Civils de Lyon-Centre Hopitalier Lyon Sud, Pierre-Bénite
Centre Léon Bérard, Lyon
OU Health Stephenson Cancer Center, Oklahoma City
Institut Curie, Paris
Hopital Pitie-Salpetriere, Paris
MD Anderson Cancer Center, Houston
Technische Universitat Munchen (TUM) - Klinikum Rechts der Isar, Munich
Huntsman Cancer Institute, Salt Lake City
Ironwood Cancer and Research Center, Chandler
UCLA Hematology/Oncology, Los Angeles
Torrance Memorial Physician Network - Cancer Care Associates, Redondo Beach
City of Hope, Duarte
Hopital Foch, Suresnes
Stanford Cancer Institute, Palo Alto
Institut Gustave Roussy, Villejuif
Providence Medical Foundation, Santa Rosa
Astera Cancer Care, East Brunswick
Queen Mary Hospital, Hong Kong
Princess Margaret Hospital, Lai Chi Kok
Hospital Clínico Universitario de Valencia, Valencia
Centrum Onkologii im. Prof. Franciszka Lukaszczyka w Bydgoszczy, Bydgoszcz
Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie, Panstwowy Instytut Badawczy, Oddzial x Gliwicach, Gliwice
Wielkopolskie Centrum Onkologii im. Marii Sklodowskiej-Curie, Oddzial Onkologii Klinicznej i Immunookologii z Poddoddzialem Dziennym i Izba Przyjec, Poznan
Wojewodzki Szpital Specjalistyczny w Siedlcach, Siedlce
Hospital de Braga, Braga
Centro Hospitalar do Algarve, Faro
Hospital CUF Descobertas, Lisbon
Unidade Local de Saude de Matosinhos EPE - Hospital Pedro Hispano SA, Matosinhos Municipality
Centro Hospitalar Universitario do Porto, Porto
Instituto Portugues de Oncologia Do Porto Francisco Gentil,E.P.E., Porto
Hospital Universitari Vall d'Hebron, Barcelona
Royal Marsden NHS Foundation Trust, Royal Marsden - Sutton, London
Musgrove Park Hospital, Taunton
Lead Sponsor
Gilead Sciences
INDUSTRY